Dynavax Technologies
DVAX
#5495
Rank
NZ$2.21 B
Marketcap
NZ$18.85
Share price
-0.64%
Change (1 day)
-13.58%
Change (1 year)

Market capitalization of Dynavax Technologies (DVAX)

Market cap: NZ$2.21 Billion

As of December 2025 Dynavax Technologies has a market cap of NZ$2.21 Billion. This makes Dynavax Technologies the world's 5495th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dynavax Technologies from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$2.21 B-26.95%
2024NZ$3.03 B6.04%
2023NZ$2.85 B33.64%
2022NZ$2.13 B-13.47%
2021NZ$2.47 B263.59%
2020NZ$0.67 B-4.6%
2019NZ$0.71 B-16.93%
2018NZ$0.85 B-46.26%
2017NZ$1.59 B626.23%
2016NZ$0.21 B-83.81%
2015NZ$1.35 B139.74%
2014NZ$0.56 B-9.69%
2013NZ$0.62 B-1.02%
2012NZ$0.63 B17.4%
2011NZ$0.53 B12.49%
2010NZ$0.47 B351.89%
2009NZ$0.10 B83.95%
2008NZ$57.68 M-78.25%
2007NZ$0.26 B-48.74%
2006NZ$0.51 B254.9%
2005NZ$0.14 B-45.06%
2004NZ$0.26 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Dynavax Technologies was reported to be:

NZ$2.21 Billion
by Nasdaq info icon info icon
NZ$2.21 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Agenus
AGEN
NZ$0.23 B-89.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$46.03 B 1,979.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$431.15 B 19,378.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$260.36 B 11,662.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$484.00 B 21,765.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
NZ$169.15 B 7,541.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
NZ$256.18 B 11,473.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$56.52 B 2,453.39%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
NZ$307.49 B 13,791.56%๐Ÿ‡บ๐Ÿ‡ธ USA